Drug Kinetics – News and Features
News
Bioengineered “Sticky” Microorganisms Help Break Down Plastic Waste
By tapping into the sticky power of mussels, researchers have engineered "sticky" microorganisms to break down plastics and help transform environmental cleanup.
Industry Insight
Getting New Drug Modalities to Market: How Can Your Data Strategy Help?
This article explores the revolution in new drug modalities and the challenges around effective data strategies to support AI efforts.
News
Nanopillars Create a "Gateway" to the Nucleus Without Damaging Cells
An array of nanopillars that can breach the nucleus of cells without damaging the membrane could open new possibilities in gene therapy.
News
Treating Hypoglycemia Via Glucose-Responsive Micelles That Encapsulate Glucagon
Researchers aim to improve commercial glucagon stability and prevent hypoglycemia by using micelles: nanoscale, soap-like bubbles that can be customized to assemble or disassemble in different environments and are used for drug delivery.
News
Combining Miniature Robots for Enhanced Surgical Performance
Researchers have developed a convoy of miniature robots capable of performing endoscopic surgeries. By combining multiple TrainBots with enhanced anti-slip feet, they successfully maneuvered an electrode through a bile duct obstruction.
Industry Insight
The Next Big Thing in Genomics? Proteomics.
In this article, explore how next-generation protein sequencing is helping to unlock the proteome.
News
Covalent Organic Frameworks May Help Speed Up PFAS Degradation
Engineers have developed an innovative way to make covalent organic frameworks (COFs), that have the potential to address significant environmental challenges, including energy storage and pollution control.
News
Scientists Develop Microbial Strain That Can Produce Polyester Materials
Researchers have manipulated a metabolic pathway in E.coli to create a strain that can produce an aromatic polyester.
News
Colon Cancer Combination Therapy May Offer Safer, More Effective Treatment
Researchers at the University of Alabama at Birmingham discovered that combining regorafenib with a dual JAK/HDAC inhibitor significantly improves treatment efficacy for metastatic colorectal cancer while minimizing toxic side effects.
News
A Virus Inspired Therapy To Target Cancer Cells
Researchers develop a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells.
Advertisement